Craft

Immunochina

Total Funding

$28.1 M

Immunochina Summary

Company Summary

Overview
Immunochina is a company that specializes in applying CAR-T technology and gene cell drugs to the treatment of malignant tumors. It provides treatments for a variety of malignant hematological tumors and solid tumors, including lymphocytic leukemia, non-Hodgkin's lymphoma, multiple myeloma, pancreatic cancer, lung cancer, and liver cancer.
Type
Private
Status
Active
Founded
2015
HQ
CN | view all locations
Website
http://www.immunochina.com/en/
Cybersecurity rating
Sectors

Table of Contents

LocationsView all

1 location detected

  • Beijing Shi HQ

    China

    Shangzhuang Rd, Haidian Qu

Footer menu